These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

461 related articles for article (PubMed ID: 30009261)

  • 21. Growth differentiation factor 15, a marker of lung involvement in systemic sclerosis, is involved in fibrosis development but is not indispensable for fibrosis development.
    Lambrecht S; Smith V; De Wilde K; Coudenys J; Decuman S; Deforce D; De Keyser F; Elewaut D
    Arthritis Rheumatol; 2014 Feb; 66(2):418-27. PubMed ID: 24504814
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adipose-derived stromal/stem cells successfully attenuate the fibrosis of scleroderma mouse models.
    Okamura A; Matsushita T; Komuro A; Kobayashi T; Maeda S; Hamaguchi Y; Takehara K
    Int J Rheum Dis; 2020 Feb; 23(2):216-225. PubMed ID: 31808305
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Decreased levels of regulatory B cells in patients with systemic sclerosis: association with autoantibody production and disease activity.
    Matsushita T; Hamaguchi Y; Hasegawa M; Takehara K; Fujimoto M
    Rheumatology (Oxford); 2016 Feb; 55(2):263-7. PubMed ID: 26350483
    [TBL] [Abstract][Full Text] [Related]  

  • 24. APRIL Induces a Novel Subset of IgA
    Fehres CM; van Uden NO; Yeremenko NG; Fernandez L; Franco Salinas G; van Duivenvoorde LM; Huard B; Morel J; Spits H; Hahne M; Baeten DLP
    Front Immunol; 2019; 10():1368. PubMed ID: 31258536
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Netrin-1 Regulates Fibrocyte Accumulation in the Decellularized Fibrotic Sclerodermatous Lung Microenvironment and in Bleomycin-Induced Pulmonary Fibrosis.
    Sun H; Zhu Y; Pan H; Chen X; Balestrini JL; Lam TT; Kanyo JE; Eichmann A; Gulati M; Fares WH; Bai H; Feghali-Bostwick CA; Gan Y; Peng X; Moore MW; White ES; Sava P; Gonzalez AL; Cheng Y; Niklason LE; Herzog EL
    Arthritis Rheumatol; 2016 May; 68(5):1251-61. PubMed ID: 26749424
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Decreased IL-10-producing regulatory B cells in patients with advanced mycosis fungoides.
    Akatsuka T; Miyagaki T; Nakajima R; Kamijo H; Oka T; Takahashi N; Suga H; Yoshizaki A; Asano Y; Sugaya M; Sato S
    Eur J Dermatol; 2018 Jun; 28(3):314-319. PubMed ID: 29952298
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 17,20S(OH)
    Brown Lobbins ML; Scott IO; Slominski AT; Hasty KA; Zhang S; Miller DD; Li W; Kim TK; Janjetovic Z; Patel TS; Myers LK; Postlethwaite AE
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445632
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Elevated serum BAFF levels in patients with systemic sclerosis: enhanced BAFF signaling in systemic sclerosis B lymphocytes.
    Matsushita T; Hasegawa M; Yanaba K; Kodera M; Takehara K; Sato S
    Arthritis Rheum; 2006 Jan; 54(1):192-201. PubMed ID: 16385515
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IL-10-producing regulatory B-cells suppressed effector T-cells but enhanced regulatory T-cells in chronic HBV infection.
    Liu Y; Cheng LS; Wu SD; Wang SQ; Li L; She WM; Li J; Wang JY; Jiang W
    Clin Sci (Lond); 2016 Jun; 130(11):907-19. PubMed ID: 26980345
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Unknown Aspect of BAFF: Inducing IL-35 Production by a CD5
    Zhang Y; Li J; Zhou N; Zhang Y; Wu M; Xu J; Shen C; An X; Shen G; Yang M; Zhang C; Tao J
    J Invest Dermatol; 2017 Dec; 137(12):2532-2543. PubMed ID: 28844943
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CD109 overexpression ameliorates skin fibrosis in a mouse model of bleomycin-induced scleroderma.
    Vorstenbosch J; Al-Ajmi H; Winocour S; Trzeciak A; Lessard L; Philip A
    Arthritis Rheum; 2013 May; 65(5):1378-83. PubMed ID: 23436317
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Expression and significance of Th17 cells and related cytokines in a murine model of systemic sclerosis].
    Lei L; Zhong XN; Zhao C; Mi CD; Li JQ; Zeng JJ
    Beijing Da Xue Xue Bao Yi Xue Ban; 2012 Apr; 44(2):259-64. PubMed ID: 22517000
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeting IL-6 by both passive or active immunization strategies prevents bleomycin-induced skin fibrosis.
    Desallais L; Avouac J; Fréchet M; Elhai M; Ratsimandresy R; Montes M; Mouhsine H; Do H; Zagury JF; Allanore Y
    Arthritis Res Ther; 2014 Jul; 16(4):R157. PubMed ID: 25059342
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of phosphodiesterase 4 (PDE4) reduces dermal fibrosis by interfering with the release of interleukin-6 from M2 macrophages.
    Maier C; Ramming A; Bergmann C; Weinkam R; Kittan N; Schett G; Distler JHW; Beyer C
    Ann Rheum Dis; 2017 Jun; 76(6):1133-1141. PubMed ID: 28209630
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Amelioration of tissue fibrosis by toll-like receptor 4 knockout in murine models of systemic sclerosis.
    Takahashi T; Asano Y; Ichimura Y; Toyama T; Taniguchi T; Noda S; Akamata K; Tada Y; Sugaya M; Kadono T; Sato S
    Arthritis Rheumatol; 2015 Jan; 67(1):254-65. PubMed ID: 25302613
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alpha2-antiplasmin regulates the development of dermal fibrosis in mice by prostaglandin F(2α) synthesis through adipose triglyceride lipase/calcium-independent phospholipase A(2).
    Kanno Y; Kawashita E; Kokado A; Okada K; Ueshima S; Matsuo O; Matsuno H
    Arthritis Rheum; 2013 Feb; 65(2):492-502. PubMed ID: 23124680
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CD43-, but not CD43+, IL-10-producing CD1dhiCD5+ B cells suppress type 1 immune responses during Chlamydia muridarum genital tract infection.
    Moore-Connors JM; Kim HS; Marshall JS; Stadnyk AW; Halperin SA; Wang J
    Mucosal Immunol; 2015 Jan; 8(1):94-106. PubMed ID: 24938746
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antifibrotic effect of lysophosphatidic acid receptors LPA1 and LPA3 antagonist on experimental murine scleroderma induced by bleomycin.
    Ohashi T; Yamamoto T
    Exp Dermatol; 2015 Sep; 24(9):698-702. PubMed ID: 25959255
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sirt1 ameliorates systemic sclerosis by targeting the mTOR pathway.
    Zhu X; Chu H; Jiang S; Liu Q; Liu L; Xue Y; Zheng S; Wan W; Qiu J; Wang J; Zou H
    J Dermatol Sci; 2017 Aug; 87(2):149-158. PubMed ID: 28532580
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel function of B cell-activating factor in the induction of IL-10-producing regulatory B cells.
    Yang M; Sun L; Wang S; Ko KH; Xu H; Zheng BJ; Cao X; Lu L
    J Immunol; 2010 Apr; 184(7):3321-5. PubMed ID: 20208006
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.